which took place in Prague, Czech Republic, including the EVOKE-02, IMscin002,

FLAURA2, MARIPOSA-2 and PAPILLON clinical trials. Hear from Federico Cappuzzo, AUSL

della Romagna-Ravenna, Ravenna, Italy, Natalia Valdiviezo, Instituto Nacional de

Enfermedades Neoplásicas, Lima, Peru, Alexander Spira, Next Oncology-Virginia VCS,

Joshua Sabari, NYU Langone Health, New York, NY, as they talk on exciting results in lung

cancer.